908 Devices Inc. (MASS)
Market Cap | 132.13M |
Revenue (ttm) | 59.63M |
Net Income (ttm) | -72.21M |
Shares Out | 35.33M |
EPS (ttm) | -2.12 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 539,571 |
Open | 3.670 |
Previous Close | 3.900 |
Day's Range | 3.575 - 3.810 |
52-Week Range | 1.810 - 7.480 |
Beta | 0.30 |
Analysts | Buy |
Price Target | 5.33 (+42.51%) |
Earnings Date | Apr 29, 2025 |
About MASS
908 Devices Inc., a commercial-stage technology company. The company provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. It also provides include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the ex... [Read more]
Financial Performance
In 2024, 908 Devices's revenue was $59.63 million, an increase of 18.72% compared to the previous year's $50.23 million. Losses were -$72.21 million, 98.4% more than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $5.33, which is an increase of 42.51% from the latest price.
News

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces that it has received a $1.7 million order from the Ministry of He...

908 Devices Makes Key Divestiture (Rating Upgrade)
908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device busines...

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
On Tuesday, Repligen Corporation RGEN purchased 908 Devices Inc.'s MASS desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ...

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer i...

908 Devices to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor c...

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and f...

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial results for the...

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
BOSTON--(BUSINESS WIRE)-- #automation--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge's bioreactors with 908 Devices' MAVEN for automated control ...

908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Kelly Gura - Gilmartin Group Kevin Knopp - Chief Executive Officer and Co-Founder Joe...

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended Septembe...

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the third quarter 2024 b...

908 Devices to Participate in Craig-Hallum Bioprocessing Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the upcoming virtual Cra...

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended June 30,...

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network
SALT LAKE CITY--(BUSINESS WIRE)--As regulatory deadlines approach, 25 snack food suppliers align with ReposiTrak for its state-of-the-art, hardware-free traceability solutions.

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the upcoming Canaccord G...

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the second quarter 2024 ...

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of ...

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
BOSTON--(BUSINESS WIRE)-- #hazmat--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an enhanced quantification package fo...

Lab Instrument Industry Update - New Commercial Entrants
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h...

908 Devices Inc. (MASS) Q1 2024 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS) Q1 2024 Results Conference Call April 30, 2024 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Co-Founder and Chief Executive Officer Joe ...

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biochemical analysis, announces that it has completed the a...

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the firs...

908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe long-ter...